These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8135801)

  • 21. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
    Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
    Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning, structure, and expression of a testicular follitropin receptor with selective alteration in the carboxy terminus that affects signaling function.
    Yarney TA; Jiang L; Khan H; MacDonald EA; Laird DW; Sairam MR
    Mol Reprod Dev; 1997 Dec; 48(4):458-70. PubMed ID: 9364440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the thyrotropin receptor and its involvement in Graves' disease.
    Kohn LD
    Horiz Biochem Biophys; 1977; 3():123-63. PubMed ID: 69601
    [No Abstract]   [Full Text] [Related]  

  • 24. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
    Haraguchi K; Saito T; Endo T; Onaya T
    Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
    Field JB; Larsen PR; Yamashita K
    Trans Assoc Am Physicians; 1973; 86():300-9. PubMed ID: 4363386
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies of thyroid glands of normal subjects and patients with Basedow's disease based on adenyl cyclase-cyclic AMP metabolism (III). Differences in reactions of the thyroid glands to TSH and PGE 1(2)].
    Takasu N; Sato M; Tsukui N; Yamada T; Miyakawa N
    Horumon To Rinsho; 1975 Oct; 23(10):1039-41. PubMed ID: 172264
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
    Tonacchera M; Van Sande J; Cetani F; Swillens S; Schvartz C; Winiszewski P; Portmann L; Dumont JE; Vassart G; Parma J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):547-54. PubMed ID: 8636266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An insertion in the human thyrotropin receptor critical for high affinity hormone binding.
    Wadsworth HL; Chazenbalk GD; Nagayama Y; Russo D; Rapoport B
    Science; 1990 Sep; 249(4975):1423-5. PubMed ID: 2169649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene.
    Costagliola S; Sunthorntepvarakul T; Migeotte I; Van Sande J; Kajava AM; Refetoff S; Vassart G
    Thyroid; 1999 Oct; 9(10):995-1000. PubMed ID: 10560953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for normal thyroidal adenyl cyclase, cyclic AMP-binding and protein-kinase activities in Graves' disease.
    Orgiazzi J; Chopra IJ; Williams DE; Solomon DH
    J Clin Endocrinol Metab; 1975 Feb; 40(2):248-55. PubMed ID: 165418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor.
    Morris JC; Jiang NS; Charlesworth MC; McCormick DJ; Ryan RJ
    Endocrinology; 1988 Jul; 123(1):456-62. PubMed ID: 3383781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple forms of thyroid stimulating hormone receptor associated with Graves' disease.
    Hunt N; Willey KP; Jähner D; Ivell R; Northemann W; Castel MA; Leidenberger F
    Exp Clin Endocrinol; 1992; 100(1-2):22-7. PubMed ID: 1468510
    [No Abstract]   [Full Text] [Related]  

  • 34. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
    Kosugi S; Shenker A; Mori T
    FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenylate cyclase system of porcine salivary gland and its relationship to thyrotropin.
    Chang TC; Chang TJ; Huang YS; Chang CC; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1987 Dec; 86(12):1245-50. PubMed ID: 2832514
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies of adenyl cyclase-cyclic AMP of the thyroid gland of the normal man and in Basedow's disease. (II). Differences in reactions of the thyroid gland to TSH and PGE 1 stimulation].
    Takasu N; Sato S; Yamada T; Miyakawa S; Kawamura N
    Horumon To Rinsho; 1975 Sep; 23(9):913-6. PubMed ID: 1242704
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of interference with the cyclic AMP-adenylcyclase-phosphodiesterase system on TSH-induced hormonal imprinting in the Tetrahymena.
    Kovács P; Csaba G
    Acta Biol Hung; 1986; 37(3-4):205-8. PubMed ID: 2831684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adenylate cyclase-cyclic AMP system in Graves' disease.
    Field JB; Muto H; Chou MC
    Adv Cyclic Nucleotide Res; 1980; 12():359-72. PubMed ID: 6250367
    [No Abstract]   [Full Text] [Related]  

  • 40. Signal transduction by the human thyrotropin receptor: studies on the role of individual amino acid residues in the carboxyl terminal region of the third cytoplasmic loop.
    Chazenbalk GD; Nagayama Y; Wadsworth H; Russo D; Rapoport B
    Mol Endocrinol; 1991 Oct; 5(10):1523-6. PubMed ID: 1663578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.